zosuquidar trihydrochloride has been researched along with fluorescite in 1 studies
Studies (zosuquidar trihydrochloride) | Trials (zosuquidar trihydrochloride) | Recent Studies (post-2010) (zosuquidar trihydrochloride) | Studies (fluorescite) | Trials (fluorescite) | Recent Studies (post-2010) (fluorescite) |
---|---|---|---|---|---|
6 | 0 | 1 | 24 | 0 | 8 |
Protein | Taxonomy | zosuquidar trihydrochloride (IC50) | fluorescite (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 0.9074 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brom, M; Cantz, T; Hofmann, AF; Keppler, D; Nies, AT | 1 |
1 other study(ies) available for zosuquidar trihydrochloride and fluorescite
Article | Year |
---|---|
MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells.
Topics: Aniline Compounds; ATP Binding Cassette Transporter, Subfamily B; Bile Acids and Salts; Biological Transport; Cell Membrane; Cyclosporine; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Immunoblotting; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Protein Isoforms; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured; Vacuoles; Xanthenes | 2000 |